Australia · Delayed Price · Currency is AUD nib holdings limited Earnings Call Transcripts
Fiscal Year 2026
-
Strong H1 FY26 results featured 22% UAOP growth, 7.7% revenue growth, and improved expense ratios. All segments contributed positively, with international and New Zealand showing notable strength, and further productivity gains and stable margins expected for FY26.
Fiscal Year 2025
-
The meeting highlighted strong financial growth, with revenue up 7.8% and a 9.4% increase in net profit. Strategic partnerships, digital innovation, and productivity gains were emphasized, while shareholders discussed inflation, regulation, and value.
-
Group UOP reached $239.2M and NPAT $198.6M, with 3.2% policyholder growth and stable margins. Productivity gains, digital transformation, and strong international and adjacent business performance underpinned results. FY 2026 outlook is positive, targeting above-system growth and further efficiency.
-
Strong first half FY25 results with 7.7% revenue growth, robust AHI performance, and improved expense ratios. Outlook remains positive with stable margins, continued digital innovation, and segment growth, despite ongoing claims inflation and regulatory challenges.
Fiscal Year 2024
-
The meeting reviewed strong financial results, with revenue and profit growth despite claims inflation and sector pressures. Strategic investments in digital health, NDIS, and AI were highlighted, along with leadership transition and ongoing focus on sustainability and risk management.
-
Underlying profit and revenue grew year-over-year, with strong digital adoption and recovery in key segments. Claims inflation is normalizing, margins are stabilizing, and new health businesses are on track for profitability. Capital position remains robust.